NLM Logo

(2''S,3aR,6S,7aR)-3''-acetyl-3a,7a-dihydro-2,2,2'-2',-tetramethyl-5'-(4-bromophenyl)-spiro(spiro(1,3-dioxolo(4,5-D)-pyrane-6(7H),5'(4'H)-1',3'-dioxolo)-7(6H),2''(3''H)-(1,3,4)-oxadiazole) MeSH Supplementary Concept Data 2025


MeSH Supplementary
(2''S,3aR,6S,7aR)-3''-acetyl-3a,7a-dihydro-2,2,2'-2',-tetramethyl-5'-(4-bromophenyl)-spiro(spiro(1,3-dioxolo(4,5-D)-pyrane-6(7H),5'(4'H)-1',3'-dioxolo)-7(6H),2''(3''H)-(1,3,4)-oxadiazole)
Unique ID
C512376
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C512376
Entry Term(s)
GLB cpd
Registry Numbers
0
Heading Mapped to
*Oxadiazoles
*Pyrans
*Spiro Compounds
Frequency
1
Note
has anti-tumor metastatic activity, which partly depends on its inhibition of tumor adhesion; structure in first source
Source
Acta Pharmacol Sin. 2005 Jul;26(7):881-6
Date of Entry
2006/08/10
Revision Date
2006/08/10
page delivered in 0.004s